NCT06417645View on ClinicalTrials.gov

Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model

PHASE4RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2024

Conditions
HealthySurgery
Interventions
DRUG

fixed propofol infusion 15 mg/kg/h until 1% BSR (burst suppression ratio)

after a slow induction with propofol to loss of consiousness (LOC), we proceed to give remifentanil TCI and rocuronium and intubate the patient. After 5 min we infuse 15 mg/kg/h until 1%BSR observe in the BIS monitor. Then we reduce the TCI LOC predicted concentration.

Trial Locations (1)

Unknown

RECRUITING

Hospital Base san José de Osorno, Osorno

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

lead

Universidad del Desarrollo

OTHER